Ophelos is proud to work with groups of investors that share the company’s vision of developing improved cancer drugs. If you are committed to this vision and want to learn more about Ophelos, please contact us at….
Ophelos understands the power of collaboration and recognizes that our technology platform may offer significant utility to other organizations looking for ways to improve the cancer targeting abilities of their lead drugs. We welcome discussion to explore potential partnerships that will advance your research and development efforts to help alleviate the suffering caused by cancer. Also, we are interested in any organizations who can help us further develop our existing prodrug pipeline. If you would like to explore a collaboration with Ophelos, please contact us at….